Kelly Dunn is a dedicated and results-driven Staff Biomechanics Systems Engineer and Product Owner at Stryker, where she plays a pivotal role in advancing innovative clinical applications and robotic technologies. With a strong foundation in systems engineering and biomedical engineering, Kelly leads cross-functional teams across...
Kelly Dunn is a dedicated and results-driven Staff Biomechanics Systems Engineer and Product Owner at Stryker, where she plays a pivotal role in advancing innovative clinical applications and robotic technologies. With a strong foundation in systems engineering and biomedical engineering, Kelly leads cross-functional teams across the US, India, and Australia, fostering collaboration and driving projects to successful completion. Her expertise in Agile software development methodologies ensures that her teams deliver high-quality applications efficiently, meeting the dynamic needs of the healthcare industry.
As the Product Owner for common software features across multiple clinical applications, Kelly is instrumental in defining and prioritizing product backlogs, ensuring that the development process aligns with user needs and market demands. One of her key projects includes serving as the System Feature Owner for Ligament Balancing on the Mako robotic system, where she leverages her deep understanding of biomechanics to enhance surgical precision and patient outcomes. Her ability to communicate complex technical concepts clearly and effectively has made her a valuable asset in bridging the gap between engineering teams and clinical stakeholders.
Kelly's commitment to continuous improvement and her competitive spirit drive her to achieve ambitious goals while maintaining a strong team-oriented approach. Her proficiency in tools such as Matlab and her background in clinical research further enrich her contributions to product development, making her a well-rounded leader in the field. With a passion for innovation and a relentless pursuit of excellence, Kelly Dunn is poised to make significant strides in the medical technology landscape.
